NewsRamp Health & Wellness Podcast

The podcast discusses various advancements and collaborations in the medical and pharmaceutical industries, including innovations in medical trends, AI data experience in prescription distribution, developments in ketamine-based therapies, breakthroughs in nanomedicine for oncology treatment, and clinical updates from companies like NanoViricides, Nutriband Inc., and Annovis Bio Inc. Various conferences and events are highlighted, showcasing the latest technologies and solutions shaping the future of medicine and healthcare.

The American Heart Association has introduced a new Digital Health in Cardiac Care certification program to enhance remote telehealth cardiac care. On the other hand, Maryland's Supplemental Nutrition Assistance Program Education (SNAP-Ed) has been defunded, impacting 640,000 residents and leaving a gap in food access for low-income families. Additionally, Rita Case donated $2 million to Cleveland Clinic Weston Hospital to support research, education, and patient care, furthering the hospital's initiatives.

VOCIC, a mobility solutions provider, is collaborating with nonprofits to enhance accessibility for individuals like Jill, enabling easier travel with mobility scooters. Meanwhile, DEFI Smart Pillbox 14, an AI-enabled medication management system by DontEverForgetIt, INC., offers cutting-edge features like real-time tracking and AI-powered auto scheduling to ensure users never miss a dose. Backers can support this innovation on Kickstarter for a glimpse into the future of medication management.

NRx Pharmaceuticals is advancing preservative-free ketamine formulations for treating depression, while Izotropic Corporation focuses on AI-driven breast cancer imaging. Calidi Biotherapeutics is developing LED therapy for targeted cancer treatment, and Datavault AI partners with Wellgistics Health to enhance prescription tracking with blockchain technology. Lantern Pharma utilizes AI for oncology drug discovery, and Dr. Catrise Austin highlights the impact of economic stress on Americans' oral health, offering solutions through Neer for smile restoration.

This podcast episode covers various advancements in the healthcare industry, including new technologies like the AVERSA Fentanyl patch by Nutriband Inc. and the BodyEstiq™ Onda Coolwaves® technology at Ovation Med Spa. It also discusses breakthroughs in Extracorporeal Liver Surgery and the challenges faced in preventing cervical cancer in China. Additionally, scholarships and grants for aspiring medical students, such as the Dr. Rodolfo Giraldi Scholarship, Dr. Gregory Facemyer Scholarship, and Dr. Azfar Malik Grant, are highlighted, along with initiatives like the implementation of the NarcBox Security System at Mary Greeley Medical Center and the Merlin CP-GEP Test for melanoma patients.

This podcast episode covers strategic shifts in Pentixapharm Holding AG, Quantum BioPharma Ltd.'s investor webinar, Izotropic Corporation's commercialization strategy, Ethema Health Corporation's acquisition, Oncotelic Therapeutics, Inc.'s abstracts presentation, NanoViricides, Inc.'s antiviral drug candidate, firearm injuries cost insights, AI-driven imaging firms in the breast cancer market, and Datavault AI and Wellgistics Health partnership for PharmacyChain(TM) integration.

AXIM Biotechnologies, Inc. partners with VisionPlus Corp. to distribute TearScan® diagnostic tests in South Korea, enhancing ocular patient care. VisionPlus will have exclusive rights to market the tests, supported by the I-Peak digital reader. In other news, Zainab Mahmoud, M.D., M.Sc., and Zhao Zhang, Ph.D., will be honored with the inaugural Jack Sarver Prize for their groundbreaking research in clinical and basic science at the American Heart Association’s Scientific Sessions 2025. Additionally, ADAP Advocacy airs a commercial calling for reforms to the 340B Drug Pricing Program, highlighting executive compensation concerns. The '340B Too Big To Fail' campaign addresses issues of declining charity and increasing patient medical debt.

Branded Legacy, Inc. is progressing the FDA pathway for its intranasal naloxone spray to combat opioid overdoses, while Izotropic Corp. introduces high-resolution 3D imaging for breast cancer screening. Additionally, new research suggests mRNA Covid vaccines may enhance cancer immunotherapy, with companies like Calidi Biotherapeutics Inc. exploring this potential. These advancements in healthcare aim to improve patient outcomes and accessibility worldwide.

BetterLife Pharma Inc. appoints Doug Drysdale as Corporate Advisor to advance BETR-001 for cluster headache and migraine. American Heart Association's updated CPR guidelines include new recommendations for choking and opioid overdose. Laonson Pill Cutter launches on Kickstarter for precise medication dosages. The Gonzales family seeks support for son in national 'Baby of the Year' competition. Dr. Robert J. Rosen named 2025 Castle Connolly Top Doctor for vascular expertise.

Oragenics Inc. has regained compliance with NYSE American's listing standards after a successful public offering, focusing on advancing brain-targeted therapeutics. Researchers are developing nanoparticles to combat scarring in alcohol-related liver disease, with implications for other organs. Investors are interested in next-generation 3D AI-imaging technologies, particularly for breast cancer detection, with companies like Izotropic Corporation leading the way. Oncotelic Therapeutics Inc. has initiated Phase 1 trials for Sapu003, a nanoparticle formulation enhancing breast cancer drug delivery.